2026-2030年全球生物感測器市場

全球生物感測器市場預計在 2025 年至 2030 年間成長至 122.816 億美元，預測期內複合年成長率為 7.7%。

本報告對全球生物感測器市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括慢性病和文明病的日益普遍、對即時診斷（POCT）需求的成長、技術進步以及持續的微型化趨勢。

本研究客觀地結合一手和二手訊息，包括主要行業相關人員的意見，進行了這項研究。報告內容包括對主要企業的分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含了歷史數據和預測數據。

本研究指出，未來幾年全球生物感測器市場成長的關鍵促進因素之一是整合數位健康生態系統的發展。此外，多參數、多功能生物感測平台的擴展，以及人們對永續生物感測器設計和環境友善生產方法的日益關注，預計也將產生巨大的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 混淆因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 2025-2030年市場展望

第5章 市場規模與表現

• 2020-2024年全球生物感測器市場
• 2020-2024年產品細分市場分析
• 2020-2024年技術細分市場分析
• 2020-2024年最終用戶細分市場分析
• 2020-2024年區域市場分析
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球生物感測器市場
• 地緣政治衝突影響全球生物感測器市場。

第7章：五力分析

• 五力模型概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 市場區隔：依產品

• 比較：按產品
• 穿戴式裝置
• 不穿戴式
• 市場機會：依產品分類

第9章 市場區隔：依技術分類

• 比較：按技術
• 電化學
• 光學
• 壓電
• 熱
• 市場機會：依技術分類

第10章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• PoC測試
• 居家醫療診斷
• 研究所
• 安全與生物防禦
• 食品工業
• 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
• 南美洲
  • 巴西
  • 阿根廷
  • 智利
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列
  • 土耳其
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• ACON Laboratories Inc.
• Agamatrix Inc.
• Bio Rad Laboratories Inc.
• Biolin Scientific AB
• Conductive Technologies Inc.
• Dexcom Inc.
• F. Hoffmann La Roche Ltd.
• LifeScan IP Holdings LLC
• Medtronic Plc
• Nova Biomedical Corp.
• Sartorius AG
• Sd Biosensor Inc.
• Siemens Healthineers AG
• Xylem Inc.

第16章附錄

The global biosensors market is forecasted to grow by USD 12281.6 mn during 2025-2030, accelerating at a CAGR of 7.7% during the forecast period. The report on the global biosensors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of chronic and lifestyle-related diseases, escalating demand for point-of-care testing diagnostics, technological advancements and persistent shift towards miniaturization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biosensors market is segmented as below:

By Product

• Wearable
• Non-wearable

By Technology

• Electrochemical
• Optical
• Piezoelectric
• Thermal

By End-User

• PoC testing
• Home healthcare diagnostics
• Research laboratories
• Security and bio-defense
• Food industry

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the advancement of integrated digital health ecosystems as one of the prime reasons driving the global biosensors market growth during the next few years. Also, expansion of multiparametric and multifunctional biosensing platforms and increasing emphasis on sustainable biosensor design and eco efficient production practices will lead to sizable demand in the market.

The report on the global biosensors market covers the following areas:

• Global biosensors market sizing
• Global biosensors market forecast
• Global biosensors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biosensors market vendors that include Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., Ascensia Diabetes Care Holdings AG, Bio Rad Laboratories Inc., Biolin Scientific AB, Conductive Technologies Inc., Cytiva, Dexcom Inc., F. Hoffmann La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Nova Biomedical Corp., Sartorius AG, Sd Biosensor Inc., Siemens Healthineers AG, Universal Biosensors Group, Xylem Inc., Zimmer and Peacock. Also, the global biosensors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biosensors Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biosensors Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biosensors market
• 6.2 Impact of geopolitical conflicts on global biosensors market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Wearable - Market size and forecast 2025-2030
• 8.4 Non-wearable - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Technology

• 9.1 Market segments
• 9.2 Comparison by Technology
• 9.3 Electrochemical - Market size and forecast 2025-2030
• 9.4 Optical - Market size and forecast 2025-2030
• 9.5 Piezoelectric - Market size and forecast 2025-2030
• 9.6 Thermal - Market size and forecast 2025-2030
• 9.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 PoC testing - Market size and forecast 2025-2030
• 10.4 Home healthcare diagnostics - Market size and forecast 2025-2030
• 10.5 Research laboratories - Market size and forecast 2025-2030
• 10.6 Security and bio-defense - Market size and forecast 2025-2030
• 10.7 Food industry - Market size and forecast 2025-2030
• 10.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing incidence of chronic and lifestyle-related diseases
  • Escalating demand for point-of-care testing diagnostics
  • Technological advancements and persistent shift towards miniaturization
• 13.2 Market challenges
  • Strict regulatory frameworks and prolonged approval cycles
  • High costs of advanced materials and scalable manufacturing
  • Stability and longevity limitations of biological recognition elements
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Advancement of integrated digital health ecosystems
  • Expansion of multiparametric and multifunctional biosensing platforms
  • Increasing emphasis on sustainable biosensor design and eco efficient production practices

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 ACON Laboratories Inc.
  • ACON Laboratories Inc. - Overview
  • ACON Laboratories Inc. - Product / Service
  • ACON Laboratories Inc. - Key offerings
  • SWOT
• 15.6 Agamatrix Inc.
  • Agamatrix Inc. - Overview
  • Agamatrix Inc. - Product / Service
  • Agamatrix Inc. - Key offerings
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 Biolin Scientific AB
  • Biolin Scientific AB - Overview
  • Biolin Scientific AB - Product / Service
  • Biolin Scientific AB - Key offerings
  • SWOT
• 15.9 Conductive Technologies Inc.
  • Conductive Technologies Inc. - Overview
  • Conductive Technologies Inc. - Product / Service
  • Conductive Technologies Inc. - Key offerings
  • SWOT
• 15.10 Dexcom Inc.
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Product / Service
  • Dexcom Inc. - Key news
  • Dexcom Inc. - Key offerings
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 LifeScan IP Holdings LLC
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product / Service
  • LifeScan IP Holdings LLC - Key offerings
  • SWOT
• 15.13 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.14 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key news
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 Sd Biosensor Inc.
  • Sd Biosensor Inc. - Overview
  • Sd Biosensor Inc. - Product / Service
  • Sd Biosensor Inc. - Key offerings
  • SWOT
• 15.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.18 Xylem Inc.
  • Xylem Inc. - Overview
  • Xylem Inc. - Business segments
  • Xylem Inc. - Key news
  • Xylem Inc. - Key offerings
  • Xylem Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations